ATAI Life Sciences NV (9VC) — Cash Flow Quality Index

Latest as of September 2023: -0.42x

ATAI Life Sciences NV (9VC) has a Cash Flow Quality Index of -0.42x as of September 2023. Operating cash flow of €-18.43 Million is below net income of €44.24 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ATAI Life Sciences NV (9VC) cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.42x

Operating CF / Net Income

Operating Cash Flow

€-18.43 Million

EUR

Net Income

€44.24 Million

EUR

Data as of

Sep 2023

Most recent filing

Annual Cash Flow Quality Index for ATAI Life Sciences NV (None–None)

Year-by-year earnings quality comparison for ATAI Life Sciences NV. For live market cap and the full company financial profile, see ATAI Life Sciences NV market capitalisation.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.